MD Medical Group opens new clinic in Vladivostok
|Download file (304 K)|
06 March 2019, Moscow– MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has opened its first out-patient clinic in Vladivostok. Investment in the project amounted toaround 50 million roubles.
Mother&Child Vladivostok has a total area of 358 sq. m. The clinicoffers a wide range of services for women including IVF, ultrasound, gynaecological treatments and antenatal care. Patients can have medical consultations with highly qualified obstetricians/gynaecoogists, endocrinologists, urologist and other specialists.
The clinic is able to carry out up to 500 IVF cycles, including under the Mandatory Health Insurance (MHI) programme,and more than 20,000 out-patient treatments per year.
The Vladivostok clinic has been created in line with MD Medical Group’s customary high standards of medical care and is fittedwith world-class equipment produced by GEHealthcare, Olympus, Origio, OxfordMedical, Linet, RocketMedicaland ZOLLMedicalCorporation.
Mark Kurtser, CEO of MD Medical Group, said:
“This is an important milestone for the Company. By opening a clinic in the capital of the Russian Far East – Vladivostok – MD Medical Goup enters a strategically important and fast-growing region where it can offer high-tech medical care. The opening of the clinic is another step in the Company’s commitment to grow a broad network of clinics and hospitals across Russia. Today, MDMG already has footprint in seven of the country’s federal districts.
“The new clinic in Vladivostok will offer a wide range of medical services focusing on women’s healthcare, including IVF under the MHI programme. We are pleased to add Mother&Child to the map in Vladivostok and believe that the high professional level of our doctors will help the clinic see demand from both residents of the city and the entirePrimorsky Region.”
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 495 331 4120
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 41modern healthcare facilities, including 5 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, and Vladivostok.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2019 2018 2017 2016 2015 2014 2013 2012